Schuth Alexander O. — SEC insider filings

SEC reporting owner CIK 1724311. 56 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers the 50 most recent of 56 filings on record, filed 2021-02-16 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Denali Therapeutics Inc. (DNLI)COFO and Secretary50—64 legs · 288,985 sh · $10,516,39137

Insider filings — Schuth Alexander O.

FiledFormIssuerReported transactionsSource
2026-11-194Denali Therapeutics Inc. (DNLI)Option exercise (M): 16,566 @ $9.60 · Option exercise (M): 16,566 (derivative) @ $0EDGAR
2026-09-034Denali Therapeutics Inc. (DNLI)Sale (S): 2,768 @ $23.44EDGAR
2026-08-134Denali Therapeutics Inc. (DNLI)Sale (S): 2,857 @ $25.07EDGAR
2026-01-084Denali Therapeutics Inc. (DNLI)Sale (S): 17,218 @ $16.50EDGAR
2026-01-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 57,700 @ $0 · Grant/award (A): 173,100 (derivative) @ $0EDGAR
2025-08-144Denali Therapeutics Inc. (DNLI)Sale (S): 2,937 @ $13.58EDGAR
2025-01-084Denali Therapeutics Inc. (DNLI)Sale (S): 12,255 @ $20.22 · Sale (S): 2,907 @ $20.81EDGAR
2025-01-074Denali Therapeutics Inc. (DNLI)Grant/award (A): 54,180 @ $0 · Grant/award (A): 162,540 (derivative) @ $0EDGAR
2024-12-314Denali Therapeutics Inc. (DNLI)Option exercise (M): 6,708 @ $5.28 · Option exercise (M): 6,708 (derivative) @ $0EDGAR
2024-11-264Denali Therapeutics Inc. (DNLI)Option exercise (M): 20,516 @ $0.68 · Option exercise (M): 20,516 (derivative) @ $0EDGAR
2024-11-124Denali Therapeutics Inc. (DNLI)Option exercise (M): 15,558 @ $5.28 · Sale (S): 12,333 @ $29.68 · Sale (S): 2,925 @ $30.72 · Sale (S): 300 @ $31.29 · Option exercise (M): 15,558 (derivative) @ $0EDGAR
2024-08-224Denali Therapeutics Inc. (DNLI)Sale (S): 2,453 @ $23.79 · Sale (S): 3,353 @ $23.54 · Sale (S): 2,547 @ $24.78EDGAR
2024-08-154Denali Therapeutics Inc. (DNLI)Sale (S): 2,272 @ $22.89EDGAR
2024-02-154Denali Therapeutics Inc. (DNLI)Sale (S): 2,716 @ $17.29 · Sale (S): 20,128 @ $17.66EDGAR
2024-02-124Denali Therapeutics Inc. (DNLI)Option exercise (M): 50,000 @ $0.68 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2024-01-094Denali Therapeutics Inc. (DNLI)Sale (S): 9,972 @ $19.43EDGAR
2024-01-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 53,720 @ $0 · Grant/award (A): 161,160 (derivative) @ $0EDGAR
2023-08-254Denali Therapeutics Inc. (DNLI)Sale (S): 2,522 @ $23.17EDGAR
2023-08-234Denali Therapeutics Inc. (DNLI)Sale (S): 2,478 @ $22.59EDGAR
2023-08-164Denali Therapeutics Inc. (DNLI)Sale (S): 2,772 @ $23.67EDGAR
2023-08-144Denali Therapeutics Inc. (DNLI)Sale (S): 2,853 @ $24.18EDGAR
2023-07-194Denali Therapeutics Inc. (DNLI)Option exercise (M): 10,000 @ $5.28 · Sale (S): 10,000 @ $29.60 · Sale (S): 9,702 @ $30.01 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-05-174Denali Therapeutics Inc. (DNLI)Option exercise (M): 10,000 @ $5.28 · Sale (S): 9,200 @ $28.55 · Sale (S): 800 @ $29.23 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-04-144Denali Therapeutics Inc. (DNLI)Option exercise (M): 5,102 @ $5.28 · Sale (S): 5,102 @ $25.04 · Option exercise (M): 4,898 @ $5.28 · Sale (S): 4,898 @ $25.04 · Option exercise (M): 5,102 (derivative) @ $0 · Option exercise (M): 4,898 (derivative) @ $0EDGAR
2023-02-154Denali Therapeutics Inc. (DNLI)Option exercise (M): 25,000 @ $0.68 · Sale (S): 3,497 @ $30.09 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2023-02-104Denali Therapeutics Inc. (DNLI)Sale (S): 1,521 @ $30.89EDGAR
2023-01-194Denali Therapeutics Inc. (DNLI)Option exercise (M): 10,000 @ $5.28 · Sale (S): 9,886 @ $29.53 · Sale (S): 114 @ $29.87 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2023-01-094/ADenali Therapeutics Inc. (DNLI)Sale (S): 2,912 @ $28.70EDGAR
2023-01-094Denali Therapeutics Inc. (DNLI)Sale (S): 2,636 @ $28.44EDGAR
2023-01-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 41,120 @ $0 · Sale (S): 2,912 @ $28.70 · Grant/award (A): 123,360 (derivative) @ $0EDGAR
2022-10-124Denali Therapeutics Inc. (DNLI)Option exercise (M): 20,000 @ $0.68 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2022-08-234Denali Therapeutics Inc. (DNLI)Sale (S): 2,576 @ $33.22EDGAR
2022-08-114Denali Therapeutics Inc. (DNLI)Grant/award (A): 22,500 @ $0EDGAR
2022-02-154Denali Therapeutics Inc. (DNLI)Sale (S): 2,803 @ $34.68EDGAR
2022-02-114Denali Therapeutics Inc. (DNLI)Sale (S): 1,423 @ $37.10EDGAR
2022-01-074Denali Therapeutics Inc. (DNLI)Sale (S): 2,846 @ $44.77EDGAR
2022-01-054Denali Therapeutics Inc. (DNLI)Grant/award (A): 31,000 @ $0 · Grant/award (A): 93,000 (derivative) @ $0EDGAR
2021-12-084Denali Therapeutics Inc. (DNLI)Sale (S): 2,800 @ $41.82 · Sale (S): 7,200 @ $42.45EDGAR
2021-11-084Denali Therapeutics Inc. (DNLI)Sale (S): 6,717 @ $52.65 · Sale (S): 3,283 @ $53.23EDGAR
2021-10-064Denali Therapeutics Inc. (DNLI)Sale (S): 5,994 @ $50.24 · Sale (S): 4,006 @ $51.04EDGAR
2021-09-224Denali Therapeutics Inc. (DNLI)Option exercise (M): 9,045 @ $0.68 · Option exercise (M): 9,045 (derivative) @ $0EDGAR
2021-09-094Denali Therapeutics Inc. (DNLI)Sale (S): 2,209 @ $54.70 · Sale (S): 5,350 @ $55.67 · Sale (S): 2,441 @ $56.05EDGAR
2021-08-234Denali Therapeutics Inc. (DNLI)Sale (S): 2,348 @ $49.56 · Sale (S): 196 @ $50.10EDGAR
2021-08-064Denali Therapeutics Inc. (DNLI)Sale (S): 1,564 @ $51.52 · Sale (S): 8,236 @ $52.34 · Sale (S): 200 @ $52.99EDGAR
2021-07-084Denali Therapeutics Inc. (DNLI)Sale (S): 10,000 @ $76.20EDGAR
2021-06-084Denali Therapeutics Inc. (DNLI)Sale (S): 5,660 @ $64.35 · Sale (S): 4,340 @ $64.82EDGAR
2021-05-064Denali Therapeutics Inc. (DNLI)Sale (S): 5,998 @ $55.09 · Sale (S): 3,557 @ $55.91 · Sale (S): 445 @ $57.39EDGAR
2021-04-064Denali Therapeutics Inc. (DNLI)Sale (S): 5,144 @ $55.60 · Sale (S): 4,156 @ $56.47 · Sale (S): 700 @ $57.44EDGAR
2021-03-044Denali Therapeutics Inc. (DNLI)Sale (S): 8,122 @ $60.89 · Sale (S): 1,878 @ $61.58EDGAR
2021-02-164Denali Therapeutics Inc. (DNLI)Sale (S): 2,614 @ $70.17 · Sale (S): 433 @ $71.41EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724311 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs